533:
29:
350:
Koehler, M; Hurwitz, CA; Krance, RA; Coustan-Smith, E; Williams, LL; Santana, V; Ribeiro, RC; Brenner, MK; Heslop, HE (1994). "XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from
161:
450:"Malcolm K. Brenner Receives the 2020 ISCT Career Achievement Award in Cell & Gene Therapy: Flexibility and Resilience Leads to Excellence in Clinical Research and Mentorship"
209:
with the intention of marking them to study their survival and fate. This seminal study demonstrated that engrafted bone marrow stem cells contribute to long-term
594:
570:
57:
37:
271:
188:
485:
378:
294:
282:
130:
255:
609:
251:
244:
563:
111:
599:
423:
83:
61:
53:
157:
90:
172:
42:
556:
259:
168:
46:
97:
17:
176:
79:
463:
589:
400:
237:
206:
336:
604:
493:
532:
184:
192:
68:
386:
360:
307:
540:
104:
311:
247:
in 2002–2003. He was appointed Editor in Chief of the journal
Molecular Therapy in 2009.
465:
Allogeneic Stem Cell
Transplantation and Other Immunotherapies for Pediatric Malignancies
254:. Dr. Brenner's is a full-time faculty member for the Center for Cell and Gene Therapy,
243:
He was
President of the International Society for Cellular Therapy and President of the
233:
583:
210:
153:
449:
198:
There, he conducted one of the first human gene therapy studies when he transduced
149:
427:
199:
224:
The move in 1994 reflected his growing interest in the genetic-modification of
221:. In 1994, he became the director of St. Jude's Cell and Gene Therapy Program.
214:
202:
364:
16:
This article is about the
British clinical scientist. For the writer, see
263:
225:
218:
180:
469:
299:
229:
379:"Introducing Molecular Therapy— Methods & Clinical Development"
175:
England. He received his medical degree and subsequent Ph.D. from
509:
267:
492:. Initial work on gene marking. 24 September 1990. Archived from
156:
applied to malignancy. In 2016, Dr. Brenner was elected to the
148:
is a
British clinical scientist working mostly in the field of
67:
from the article and its talk page, especially if potentially
22:
316:
162:
National
Academies of Sciences, Engineering, and Medicine
195:
as the director of the Bone Marrow
Transplant Division.
544:
304:
337:"National Academy of Medicine Elects 80 New Members"
279:
183:. In the 1980s, he was a Lecturer in Hematology at
305:American Society of Gene & Cellular Therapy
283:International Society of Cell and Gene Therapy
187:in London. In 1990, he left the UK to work in
564:
8:
539:This article about a British scientist is a
213:and also that contaminating tumor cells in
571:
557:
300:International Society for Cellular Therapy
250:Dr. Brenner was appointed Director of the
60:about living persons that is unsourced or
272:European Society of Gene and Cell Therapy
131:Learn how and when to remove this message
462:Malcolm K. Brenner (22 September 2005).
328:
295:Center for Cell and Gene Therapy (CAGT)
270:. In 2017, Dr. Brenner was awarded the
258:and the Dan L. Duncan Cancer Center at
595:Alumni of Emmanuel College, Cambridge
189:St. Jude Children's Research Hospital
7:
529:
527:
543:. You can help Knowledge (XXG) by
510:"Center for Cell and Gene Therapy"
402:Dr. Malcolm Brenner's Faculty Page
14:
531:
405:, Texas Children's Cancer Center
252:Center for Cell and Gene Therapy
245:American Society of Gene Therapy
27:
256:Texas Children's Cancer Center
1:
486:"Giant Step for Gene Therapy"
275:Outstanding Achievement Award
158:National Academy of Medicine
38:biography of a living person
351:matched unrelated donors".
173:Emmanuel College, Cambridge
65:must be removed immediately
626:
526:
260:Baylor College of Medicine
169:Forest School, Walthamstow
15:
310:29 November 2009 at the
18:Malcolm Brenner (writer)
610:British scientist stubs
353:Bone Marrow Transplant
52:Please help by adding
600:British immunologists
389:on 29 September 2013.
238:monoclonal antibodies
177:Cambridge University
58:Contentious material
185:Royal Free Hospital
167:He was educated at
430:on 7 November 2017
339:. 17 October 2016.
277:, and in 2020 the
146:Malcolm K. Brenner
552:
551:
383:Molecular Therapy
317:Molecular Therapy
207:retroviral vector
141:
140:
133:
115:
80:"Malcolm Brenner"
41:needs additional
617:
573:
566:
559:
535:
528:
520:
518:
516:
505:
503:
501:
496:on 13 April 2009
481:
479:
477:
472:on 14 April 2013
468:. Archived from
454:
453:
446:
440:
439:
437:
435:
426:. Archived from
420:
414:
413:
412:
410:
397:
391:
390:
385:. Archived from
375:
369:
368:
347:
341:
340:
333:
136:
129:
125:
122:
116:
114:
73:
54:reliable sources
31:
30:
23:
625:
624:
620:
619:
618:
616:
615:
614:
580:
579:
578:
577:
524:
514:
512:
508:
499:
497:
484:
475:
473:
461:
458:
457:
448:
447:
443:
433:
431:
422:
421:
417:
408:
406:
399:
398:
394:
377:
376:
372:
349:
348:
344:
335:
334:
330:
325:
312:Wayback Machine
291:
234:cancer vaccines
137:
126:
120:
117:
74:
72:
51:
32:
28:
21:
12:
11:
5:
623:
621:
613:
612:
607:
602:
597:
592:
582:
581:
576:
575:
568:
561:
553:
550:
549:
536:
522:
521:
506:
482:
456:
455:
441:
424:"ESGCT Awards"
415:
392:
370:
342:
327:
326:
324:
321:
320:
319:
314:
302:
297:
290:
289:External links
287:
160:, part of the
139:
138:
62:poorly sourced
35:
33:
26:
13:
10:
9:
6:
4:
3:
2:
622:
611:
608:
606:
603:
601:
598:
596:
593:
591:
590:Living people
588:
587:
585:
574:
569:
567:
562:
560:
555:
554:
548:
546:
542:
537:
534:
530:
525:
511:
507:
495:
491:
490:Time Magazine
487:
483:
471:
467:
466:
460:
459:
451:
445:
442:
429:
425:
419:
416:
404:
403:
396:
393:
388:
384:
380:
374:
371:
366:
362:
358:
354:
346:
343:
338:
332:
329:
322:
318:
315:
313:
309:
306:
303:
301:
298:
296:
293:
292:
288:
286:
284:
280:
276:
273:
269:
265:
261:
257:
253:
248:
246:
241:
239:
235:
231:
227:
222:
220:
216:
212:
211:hematopoiesis
208:
204:
201:
196:
194:
190:
186:
182:
178:
174:
170:
165:
163:
159:
155:
154:immunotherapy
151:
147:
143:
135:
132:
124:
113:
110:
106:
103:
99:
96:
92:
89:
85:
82: –
81:
77:
76:Find sources:
70:
66:
63:
59:
55:
49:
48:
44:
39:
34:
25:
24:
19:
545:expanding it
538:
523:
513:. Retrieved
498:. Retrieved
494:the original
489:
474:. Retrieved
470:the original
464:
444:
432:. Retrieved
428:the original
418:
407:, retrieved
401:
395:
387:the original
382:
373:
359:(5): 571–5.
356:
352:
345:
331:
278:
274:
249:
242:
223:
197:
166:
150:gene therapy
145:
144:
142:
127:
118:
108:
101:
94:
87:
75:
64:
47:verification
40:
605:1951 births
409:13 December
200:bone marrow
584:Categories
476:15 January
434:1 November
323:References
217:can cause
215:autografts
203:stem cells
121:March 2024
91:newspapers
281:from the
232:therapy,
43:citations
308:Archived
69:libelous
365:7519937
264:Houston
226:T-cells
219:relapse
205:with a
193:Memphis
181:England
105:scholar
515:30 May
500:30 May
363:
230:cancer
107:
100:
93:
86:
78:
268:Texas
112:JSTOR
98:books
36:This
541:stub
517:2007
502:2007
478:2024
436:2017
411:2013
361:PMID
236:and
228:for
171:and
152:and
84:news
45:for
191:in
586::
488:.
381:.
357:13
355:.
285:.
266:,
262:,
240:.
179:,
164:.
56:.
572:e
565:t
558:v
547:.
519:.
504:.
480:.
452:.
438:.
367:.
134:)
128:(
123:)
119:(
109:·
102:·
95:·
88:·
71:.
50:.
20:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.